Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors

Carcinogenesis

Volumn 20, Issue 2, 1999, Pages 185-191

  Shao, Jinyi ^a   Sheng, Hongmiao ^a   Aramandla, Radhika ^a   Pereira, Michael A ^b   Lubet, Ronald A ^c   Hawk, Ernest ^c   Grogan, Liam ^c   Kirsch, Ilan R ^c   Washington, M Kay ^a   Beauchamp, R Daniel ^a,d   DuBois, Raymond N ^a,d,e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DNA REPLICATION; ENZYME INDUCTION; ENZYME REGULATION; GENE INDUCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; LIVER METASTASIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

EID: 0032927779     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.2.185     Document Type: Article

References (53)

1. Thun, M.J., Namboodiri, M.M. and Heath, C.W.J. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596.
2. Thun, M.J., Namboodiri, M.M., Calle, E.E., Flanders, W.D. and Heath, C.W.J. (1993) Aspirin use and risk of fatal cancer. Cancer Res., 53, 1322-1327.
3. Giovannucci, E., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Ascherio, A. and Willett, W.C. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121, 241-246.
4. Giovannucci, E., Egan, K.M., Hunter, D.J., Stampfer, M.J. Colditz, G.A., Willett, W.C. and Speizer, F.E. (1995) Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333, 609-614.
5. Greenberg, E.R., Baron, J.A., Freeman, D.H.J., Mandel, J.S. and Haile, R. (1993) Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J. Natl Cancer. Inst., 85, 912-916.
6. Peleg, I.I., Maibach, H.T., Brown, S.H. and Wilcox, C.M. (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern. Med., 154, 394-399.
7. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
8. Waddell, W.R., Gasner, G.F., Cerise, E.J. and Loughry, R.W. (1989) Sulindac for polyposis of the colon. Am. J. Surg., 157, 175-178.
9. Waddell, W.R. and Loughry, R.W. (1983) Sulindac for polyposis of the colon. J. Surg. Oncol., 24, 83-87.
10. Winde, G., Gumbinger, H.G., Osswald, H., Kemper, F. and Bunte, H. (1993) The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int. J. Colorectal Dis., 8, 13-17.
11. Nugent, K.P., Farmer, K.C., Spigelman, A.D., Williams, C.B. and Phillips, R.K. (1993) Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br. J. Surg., 80, 1618-1619.
12. Reddy, B., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. and Kelloff, G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D.L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res., 50, 2562-2568.
13. Reddy, B.S., Rao, C.V., Rivenson, A. and Kelloff, G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497.
14. Craven, P.A. and DeRubertis, F.R. (1992) Effects of aspirin on 1.2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis, 13, 541-546.
15. Reddy, B.S., Rao, C.V. and Seibert, K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.
16. Kawamori, T., Rao, C.V., Seibert, K. and Reddy, B.S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412.
17. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
18. Kargman, S., O'Neill, G., Vickers, P., Evans, J., Mancini, J. and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559.
19. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
20. DuBois, R.N., Radhika, A., Reddy, B.S. and Entingh, A.J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110, 1259-1262.
21. Williams, C.S., Luongo, C., Radhika, A., Zhang, T., Lamps, L.W., Nanney, L.B., Beauchamp, R.D. and DuBois, R.N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111, 1134-1140.
22. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
23. Prescott, S.M. and White, R.L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87, 783-786.
24. Massague, J. and Polyak, K. (1995) Mammalian antiproliferative signals and their targets. Curr. Opin. Genet. Dev., 5, 91-96.
25. Alexandrow, M.G. and Moses, H.L. (1995) Transforming growth factor beta and cell cycle regulation. Cancer Res., 55, 1452-1457.
26. Thompson, E.A., Ko, T.C. and Beauchamp, R.D. (1996) TGF-b Inhibition of Intestinal Epithelial Cell Proliferation: G1 Cyclins, Cyclin-Dependent Kinases and Cyclin Kinase Inhibitors. Birkhauser, Boston, MA.
27. Kurokowa, M., Lynch, K. and Podolsky, D.K. (1987) Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun., 142, 775-782.
28. Barnard, J.A., Beauchamp, R.D., Coffey, R.J. and Moses, H.L. (1989) Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc. Natl Acad. Sci. USA, 86, 1578-1582.
29. Filmus, J., Zhao, J. and Buick, R.N. (1992) Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-beta 1) and alters the number and type of TGF-beta 1 receptors in rat intestinal epithelial cell clones. Oncogene, 7, 521-526.
30. Ko, T.C., Beauchamp, R.D., Townsend, C.M.Jr and Thompson, J.C. (1993) Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation [see comments]. Surgery, 114, 147-153 [discussion 153-154].
31. Torre-Amione, G., Beauchamp, R.D., Koeppen, H., Park, B.H., Schreiber, H., Moses, H.L. and Rowley, D.A. (1990) A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. Natl Acad. Sci. USA, 87, 1486-1490.
32. Sieweke, M.H., Thompson, N.L., Sporn, M.B. and Bissell, M.J. (1990) Mediation of wound-related Rous-sarcoma virus tumorigenesis by TGF-β. Science, 248, 1656-1660.
33. Sieweke, M.H. and Bissell, M.J. (1994) The tumor-promoting effect of wounding: a possible role for TGF-beta-induced stromal alterations. Crit. Rev. Oncog., 5, 297-311.
34. Zhang, X., Wang, T., Balist, G. and Tsao, M.S. (1994) Transforming growth factor beta 1 promotes spontaneous transformation of cultured rat liver epithelial cells. Cancer Res., 54, 6122-6128.
35. Cui, W., Fowlis, D.J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. and Akhurst, R.J. (1996) TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86, 531-542.
36. Oft, M., Peli, J., Rudaz, C. Schwarz, H., Beug, H. and Reichmann, E. (1996) TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev., 10, 2462-2477.
37. Gilbert, R.S., Reddy, S.T., Kujubu, D.A., Xie, W., Luner, S. and Herschman, H.R. (1994) Transforming growth factor betal augments mitogen-induced prostaglandin synthesis and expression of the TIS10/ prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts. J. Cell. Physiol., 159, 67-75.
38. Gilbert, R.S., Reddy, S.T., Targan, S. and Herschman, H.R. (1994) TGF-beta 1 augments expression of ths TIS10/prostaglandin synthase-2 gene in intestinal epithelial cells. Cell. Mol. Biol. Res., 40, 653-660.
39. Pilbeam, C., Rao, Y., Voznesensky, O., Kawaguchi, H., Alander, C., Raisz, L. and Herschman, H. (1997) Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells. Endocrinology, 138, 4672-4682.
40. Li, J., Simmons, D.L. and Tsang, B.K. (1996) Regulation of hen granulosa cell prostaglandin production by transforming growth factors during follicular development: involvement of cyclooxygenase II. Endocrinology, 137, 2522-2529.
41. Sheng, H., Shao, J., Hooton, E.B., Tsujii, M., DuBois, R.N. and Beauchamp, R.D. (1997) Cyclooxygenase-2 induction and transforming growth factor (TGF)-β growth inhibition in rat intestinal epithelial cells. Cell Growth Differ., 8, 463-470.
42. Avery, A., Paraskeva, C., Hall, P., Flanders, K.C., Sporn, M. and Moorghen, M. (1993) TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br. J. Cancer, 68, 137-139.
43. Kitaeva, M.N., Grogan, L., Williams, J.P., Dimond, E., Nakahara, K., Hausner, P., DeNobile, J.W., Soballe, P.W. and Kirsch, I.R. (1997) Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res., 57, 4478-4481.
44. Sheng, H., Shao, J., Kirkland, S.C. Isakson, P., Coffey, R.J., Morrow, J.D., Beauchamp, R.D. and DuBois, R.N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259.
45. Barnard, J.A., Warwick, G.J. and Gold, L.I. (1993) Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology, 105, 67-73.
46. Aaltonen, L.A., Peltomaki, P., Leach, F.S. et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science, 260, 812-816.
47. Parsons, R., Myeroff, L.L., Liu, B., Willson, J.K.V., Markowitz, S.D., Kinzler, K.W. and Vogelstein, B. (1995) Microsatellite instability and mutations of the transforming growth factor P type II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550.
48. Chen, R.-H., Ebner, R. and Derynck, R. (1993) Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science, 260, 1335-1338.
49. Caulin, C., Scholl, F.G., Frontelo, P., Gamallo, C. and Quintanilla, M. (1995) Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β1 induces an epithelial-mesenchymal transdifferentiation and spindle tumoral phenotype. Cell Growth Differ., 6, 1027-1035.
50. Tsujii, M. and DuBois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
51. Sheng, G.G., Shao, J., Sheng, H., Hooton, E.B., Isakson, P.C., Morrow, J.D., Coffey, R.J., DuBois, R.N. and Beauchamp, R.D. (1997) A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras transformed rat intestinal epithelial cells. Gastroenterology, 113, 1883-1891.
52. 2 in human colon cancer cells. Cancer Res., 58, 362-366.
53. Sheng, H., Shao, J., O'Mahony, C.A., Lamps, L., Albo, D., Isakson, P.C., Berger, D.H., DuBois, R.N. and Beauchamp, R.D. (1998) Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2. Oncogene, 17, in press.